The US Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi and partner AstraZeneca s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.
Recently, the venerable system has increasingly come under fire for colorism and racial bias, with some calling for an overhaul. The controversy stems from the 2 points allotted for an overall pink skin tone.